Children with growth hormone deficiency (GHD) have differences in gut microbiota and microbial metabolites from both individuals with idiopathic short stature (ISS) and healthy controls, suggesting an ...

Add Yahoo as a preferred source to see more of our stories on Google. Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

Growth hormone treatment is a safe and effective therapy that's often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

Growth Hormone Deficiency (GHD) is characterised by inadequate secretion of growth hormone, a peptide hormone pivotal to somatic growth and metabolic regulation. Management begins with careful ...

The once-weekly growth hormone analog somapacitan (Sogroya, Novo Nordisk) has been given the green light in both Europe and the United States for the treatment of children and adolescents with growth ...

Growth hormone therapy has become a cornerstone in the management of paediatric and adolescent short stature arising from a variety of underlying causes. Originally approved for classical growth ...

Strong emotional links between children with chronic conditions and their family caregivers suggest that improving parent well-being may directly benefit a child's overall health and coping mechanisms ...

An unexpected observation has led researchers at the Weizmann Institute of Science to challenge a 200-year-old doctrine regarding the embryonic origins of the pituitary gland. Situated at the base of ...

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...